Go Ad-Free
    My Alerts
    VICTORIS
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv
    Loans
    Loans
    HomeNewsKamal k sharma

    Kamal K Sharma

    Jump to

    • Lupin gets shareholders nod to raise up to Rs 7,500 crore

      Drug major Lupin on Saturday said it has received approval from its shareholders to raise up to Rs 7,500 crore through issue of securities.

    • Expect margins to improve by 100bps in FY13: Lupin

      In an interview to CNBC-TV18, Lupin Managing Director Kamal K. Sharma analysed the performance of the company in the second quarter.

    • The Japanese are a brand conscious people, says Lupin MD

      In Japan, work gets done only after building consensus, says Kamal K Sharma, Lupin MD

    • Could exceed earlier outlined guidance: Lupin

      In an interview to CNBC-TV18, Dr Kamal K Sharma, managing director, Lupin said, the company will be able to maintain its performance during the year.

    • Expect to improve EBITDA margin by 75 bps ahead: Lupin

      Lupin has declared its fourth quarter results. Kamal K Sharma, MD, Lupin says, the company’s endeavour would be to grow around 25% year-on-year (YoY) on organic basis, unless it makes some inorganic moves that could be additive. “Our attempt has always been to improve on EBITDA margins by atleast 75 bps,” he adds.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347